Copyright Reports & Markets. All rights reserved.

Global Chorea Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Chorea Treatment Market Overview

    • 1.1 Product Overview and Scope of Chorea Treatment
    • 1.2 Classification of Chorea Treatment by Types
      • 1.2.1 Global Chorea Treatment Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Chorea Treatment Revenue Market Share by Types in 2018
      • 1.2.3 Medication
      • 1.2.4 Surgery Therapy
    • 1.3 Global Chorea Treatment Market by Application
      • 1.3.1 Global Chorea Treatment Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospitals
      • 1.3.3 Clinics
      • 1.3.4 Others
    • 1.4 Global Chorea Treatment Market by Regions
      • 1.4.1 Global Chorea Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Chorea Treatment Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Chorea Treatment Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chorea Treatment Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Chorea Treatment Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chorea Treatment Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Chorea Treatment (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Medtronic
      • 2.1.1 Business Overview
      • 2.1.2 Chorea Treatment Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Medtronic Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Boston Scientific
      • 2.2.1 Business Overview
      • 2.2.2 Chorea Treatment Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Boston Scientific Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Aleva Neurotherapeutics
      • 2.3.1 Business Overview
      • 2.3.2 Chorea Treatment Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Aleva Neurotherapeutics Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Teva Pharmaceutical
      • 2.4.1 Business Overview
      • 2.4.2 Chorea Treatment Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Teva Pharmaceutical Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Pfizer
      • 2.5.1 Business Overview
      • 2.5.2 Chorea Treatment Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Pfizer Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 GlaxoSmithKline
      • 2.6.1 Business Overview
      • 2.6.2 Chorea Treatment Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 GlaxoSmithKline Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Bausch Health Companies
      • 2.7.1 Business Overview
      • 2.7.2 Chorea Treatment Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Bausch Health Companies Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 LivaNova
      • 2.8.1 Business Overview
      • 2.8.2 Chorea Treatment Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 LivaNova Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Lundbeck
      • 2.9.1 Business Overview
      • 2.9.2 Chorea Treatment Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Lundbeck Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Ipsen
      • 2.10.1 Business Overview
      • 2.10.2 Chorea Treatment Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Ipsen Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Alnylam Pharmaceuticals
      • 2.11.1 Business Overview
      • 2.11.2 Chorea Treatment Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Alnylam Pharmaceuticals Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Prana Biotechnology
      • 2.12.1 Business Overview
      • 2.12.2 Chorea Treatment Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Prana Biotechnology Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 RespireRx Pharmaceuticals
      • 2.13.1 Business Overview
      • 2.13.2 Chorea Treatment Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 RespireRx Pharmaceuticals Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Vertex Pharmaceuticals
      • 2.14.1 Business Overview
      • 2.14.2 Chorea Treatment Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Vertex Pharmaceuticals Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 SOM Biotech
      • 2.15.1 Business Overview
      • 2.15.2 Chorea Treatment Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 SOM Biotech Chorea Treatment Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Chorea Treatment Market Competition, by Players

    • 3.1 Global Chorea Treatment Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Chorea Treatment Players Market Share
      • 3.2.2 Top 10 Chorea Treatment Players Market Share
    • 3.3 Market Competition Trend

    4 Global Chorea Treatment Market Size by Regions

    • 4.1 Global Chorea Treatment Revenue and Market Share by Regions
    • 4.2 North America Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 4.5 South America Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Chorea Treatment Revenue and Growth Rate (2014-2019)

    5 North America Chorea Treatment Revenue by Countries

    • 5.1 North America Chorea Treatment Revenue by Countries (2014-2019)
    • 5.2 USA Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Chorea Treatment Revenue and Growth Rate (2014-2019)

    6 Europe Chorea Treatment Revenue by Countries

    • 6.1 Europe Chorea Treatment Revenue by Countries (2014-2019)
    • 6.2 Germany Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 6.3 UK Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 6.4 France Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Chorea Treatment Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Chorea Treatment Revenue by Countries

    • 7.1 Asia-Pacific Chorea Treatment Revenue by Countries (2014-2019)
    • 7.2 China Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 7.5 India Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Chorea Treatment Revenue and Growth Rate (2014-2019)

    8 South America Chorea Treatment Revenue by Countries

    • 8.1 South America Chorea Treatment Revenue by Countries (2014-2019)
    • 8.2 Brazil Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Chorea Treatment Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Chorea Treatment by Countries

    • 9.1 Middle East and Africa Chorea Treatment Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Chorea Treatment Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Chorea Treatment Revenue and Growth Rate (2014-2019)

    10 Global Chorea Treatment Market Segment by Type

    • 10.1 Global Chorea Treatment Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Chorea Treatment Market Forecast by Type (2019-2024)
    • 10.3 Medication Revenue Growth Rate (2014-2024)
    • 10.4 Surgery Therapy Revenue Growth Rate (2014-2024)

    11 Global Chorea Treatment Market Segment by Application

    • 11.1 Global Chorea Treatment Revenue Market Share by Application (2014-2019)
    • 11.2 Chorea Treatment Market Forecast by Application (2019-2024)
    • 11.3 Hospitals Revenue Growth (2014-2019)
    • 11.4 Clinics Revenue Growth (2014-2019)
    • 11.5 Others Revenue Growth (2014-2019)

    12 Global Chorea Treatment Market Size Forecast (2019-2024)

    • 12.1 Global Chorea Treatment Market Size Forecast (2019-2024)
    • 12.2 Global Chorea Treatment Market Forecast by Regions (2019-2024)
    • 12.3 North America Chorea Treatment Revenue Market Forecast (2019-2024)
    • 12.4 Europe Chorea Treatment Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Chorea Treatment Revenue Market Forecast (2019-2024)
    • 12.6 South America Chorea Treatment Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Chorea Treatment Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disorders, paraneoplastic syndromes, hyperthyroidism, hypoparathyroidism, and hyperglycemia.

      Scope of the Report:
      The global Chorea Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chorea Treatment.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Chorea Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chorea Treatment market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Medtronic
      Boston Scientific
      Aleva Neurotherapeutics
      Teva Pharmaceutical
      Pfizer
      GlaxoSmithKline
      Bausch Health Companies
      LivaNova
      Lundbeck
      Ipsen
      Alnylam Pharmaceuticals
      Prana Biotechnology
      RespireRx Pharmaceuticals
      Vertex Pharmaceuticals
      SOM Biotech

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Medication
      Surgery Therapy

      Market Segment by Applications, can be divided into
      Hospitals
      Clinics
      Others

      Buy now